2 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow TAB08: new trials by email Literature Review of TAB08 trials Research Report on TAB08
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment TAB08, Placebo - Psoriasis Vulgaris | Phase 1 / Phase 2 | Completed | Theramab LLC | 9 | 2016-04-01 | 2017-02-15 |
| TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment TAB08, Placebo - Lupus Erythematosus, Systemic | Phase 2 | Terminated | Theramab LLC | 60 | 2016-03-01 | 2018-05-23 |
| Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis TAB08 - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Theramab LLC | 18 | 2013-11-01 | 2017-02-28 |
Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1)
Theramab LLC (3)
Russia (3)
Daniil Nemenov, M.D. (2) · Daniil G Nemenov, M.D. (1)